LITTLE KNOWN FACTS ABOUT NKP608.

), helps to explain why KIF15 can aid resistance to Eg5 inhibitors in vivo. MT gliding powered by both equally of these mitotic motors was arrested only if they had been individually inhibited, lending support on the proposal that a mix drug therapy targeting these motors could be a workable strategy for overcoming chemotherapeutic resistance to Eg